Skip to content
Telehealth Graded
State guide

South Carolina Medicaid and GLP-1s

South Carolina added GLP-1s for weight management in November 2024 and took them out again on January 1, 2026. What makes this one unusual isn't the decision, it's how you'd find out: there's no bulletin. The record is two lines in a change log attached to the pharmacy provider manual.

Every source on this page was read first-hand in September 2026, and each one below carries the date printed on the document itself.

2
documents cited
5
sourced facts
2
primary sources

What changed, and what the document says

  1. Removed from the manual

    Not covered

    Two entries in the change log, both dated 1/1/2026, both stripping GLP-1 language out of the pharmacy manual.

    “Remove GLP1 language for weight loss”

    South Carolina Department of Health and Human Services — Updated 07/01/26.

  2. The second entry

    Not covered

    The utilization-management section lost its GLP-1 language the same day.

    “Remove GLP1 receptor Agonists language”

    South Carolina Department of Health and Human Services — Updated 07/01/26.

  3. How long it lasted

    Context

    The same log shows the benefit going in on November 1, 2024. Fourteen months, start to finish.

    “Added GLP-1 Receptor Agonists for weight management coverage”

    South Carolina Department of Health and Human Services — Updated 07/01/26.

  4. What the manual says now

    Not covered

    Weight control products are on the excluded list, with no exceptions written into it.

    “The following is a listing of products excluded from Healthy Connections coverage. These items are considered non-covered, regardless of circumstance:”

    South Carolina Department of Health and Human Services — JULY 1, 2026

  5. What the state does not say

    Conditions apply

    Neither document mentions diabetes, sleep apnea or cardiovascular use. Every other state on this site publishes what stays covered. South Carolina's pharmacy manual doesn't contain the string "GLP" at all, so we can't tell you.

    “Weight control products”

    South Carolina Department of Health and Human Services — JULY 1, 2026

Telehealth in South Carolina

Some providers pay us a commission when you sign up through our links, at no extra cost to you.

What the state didn't publish

South Carolina's Medicaid agency published no bulletin, provider notice or web announcement about ending this coverage.

We looked at 344 documents to say that — every bulletin title listed in the agency's own communications archive, paged from the first page to the last.

The same scan, in the same run, found 121 titles containing "provider," 2 containing "pharmacy" and 1 containing "hospice" — so the scan can find things. Against the same 344 titles, the terms GLP, Wegovy, Zepbound, Saxenda, semaglutide, tirzepatide, liraglutide, obesity and weight returned zero.

Checked September 2026 against Communications — the agency's own bulletin archive, South Carolina Department of Health and Human Services.

Which of these companies serve South Carolina?

Of the 284 companies we grade, 28 publish a list of the states they are licensed in. We checked 250 more and found no such list on any page we read; 6 we have not checked either way.

15 of those lists name South Carolina: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, WePeptideRx, Ways2Well, Tyde Wellness, Willow, VevaRx, Trimi, HumeCare+, Rx.com, Mojoon, Peak Wellness, and Sprout Health. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Coverage decides what you pay before cash does. See how state Medicaid programs cover GLP-1s and what a prior-authorization denial turns on.

Sources

Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026.

Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.